RIM
BMY icon

Reynolds Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Reynolds Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$714K Buy
9,272
+55
+0.6% +$4.19K 0.25% 62
2022
Q1 		$673K Buy
+9,217
New +$619K 0.2% 72

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Reynolds Investment Management's BMY Position: Q2 2022 in Review

Reynolds Investment Management increased its Bristol-Myers Squibb (BMY) stake by 0.6% in Q2 2022, buying an estimated $4.19K and bringing the position to 9,272 shares worth $714K. The position accounts for 0.25% of the portfolio, ranked #62.

Reynolds Investment Management first reported a position in BMY in Q1 2022 and has held it in 2 quarters since. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

  • Reynolds Investment Management held 9,272 shares of Bristol-Myers Squibb worth $714K as of Q2 2022.
  • Reynolds Investment Management bought 55 Bristol-Myers Squibb shares in Q2 2022, an estimated $4.19K.
  • Bristol-Myers Squibb made up 0.25% of Reynolds Investment Management's portfolio in Q2 2022, its #62 holding.
  • Reynolds Investment Management first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 2 quarters since.
  • 2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Reynolds Investment Management's 13F filing for Q2 2022, filed 27 Jul 2022.